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Surgery and interventional cardiology have developed greatly during the
last decades. For any congenital heart disease a surgical procedure is
possible to obtain complete correction or acceptable palliation. Progress in
interventional cardiology opens up new directions for the treatment of
simple heart defects. Today many simple lesions are suitable for correction
in the catheterisation laboratory. Since the beginning of this century long-
term follow-up studies and developmental surveys have been published.1-3
Paediatric patients with congenital heart disease, particularly those who
need an intervention in the perinatal period or repeated surgeries,
demonstrate different kinds of disability at school age. Although
cardiopulmonary bypass is a huge advance, it also has detrimental effects. 
Confronted with these observations, new strategies have been developed
to shorten cardiopulmonary bypass or to avoid particularly risky surgical
approaches. These new strategies are called hybrid procedures because
they emerge from the collaborative efforts of cardiac surgeons and
interventional cardiologists in an approach to managing congenital heart
disease. The idea is to develop therapies that offer the advantages of
surgery and interventional techniques in the same setting.4,5
Hybrid therapy is not a simple first step. It is a change in approach for
surgeons and cardiologists. Both have to admit that joining the two
techniques would possibly allow better immediate and long-term results.
It also means that cardiologists can enter the operating theatre for other
reasons than only to look at the transoesophageal echocardiography
(TEE) and that surgeons can enter the catheterisation laboratory not only
for emergency purposes. In other words, surgeons and cardiologists have
to discuss and collaborate in a positive fashion.
Indications for hybrid therapy are expanding, the most frequent being
intraoperative stenting, perventricular ventricular septal defect (VSD)
closure, occlusion of vascular structures during surgical repair and
percutaneous palliation for single ventricle physiology (such as
hypoplastic left heart syndrome [HLHS]). Ideally, these interventions are
carried out in a hybrid suite where operating room and catheterisation
laboratory facilities are brought together.
Indications, Techniques and Experience
Hypoplastic Left Heart Syndrome 
HLHS associates hypoplastic left ventricle (unsuitable for systemic
perfusion), aortic valve stenosis and hypoplasia of the ascending aorta.
Since the 1980s a three-step surgical palliation can be proposed for these
infants. The first step is Norwood stage I, whereby reconstruction of the
aortic arch with anastomosis to the pulmonary trunk is performed. At the
same time pulmonary blood flow is provided with a modified Blalock-
Taussig shunt or a shunt between the right ventricle and pulmonary
arteries. The second step, Norwood stage II, is a bidirectional Glenn
anastomosis. The third step is the completion of a Fontan circulation, with
a connection between inferior vena cava and pulmonary arteries. 
HLHS is a typical congenital cardiac malformation with the first surgical
palliation occurring in the first days after birth, in which high surgical
mortality and high long-term morbidity have been reported. Some authors
have demonstrated a striking association for these infants between
duration of deep hypothermic circulatory arrest performed during this
surgical procedure and developmental outcome at school age.1
In an attempt to change the traditional surgical strategy, hybrid therapy
combines stent implantation in the ductus arteriosus by the interventional
cardiologist and a surgical band for both pulmonary arteries, in order to
maintain systemic perfusion and restrict pulmonary blood flow to the
lungs. Usually, this procedure is completed with a unique step through a
median sternotomy without the need for cardiopulmonary bypass.6,7 A
few months later, with a larger infant, a comprehensive stage I and II
Norwood is performed. The main advantage of this technique is to
postpone the Norwood I procedure to a later age, allowing a decreasing
global risk of this surgical procedure in the neonatal period and avoiding
deep hypothermic circulatory arrest. Reconstruction of the aortic arch is
then carried out in a larger infant, with a probable decreased risk of brain
insult than in the neonatal period. The second advantage is to reduce the
number of interventions with cardiopulmonary bypass. 
As for any new surgical or interventional procedure there is a learning curve.
Initial problems have been identified and can be overcome. For example,
tightening of the pulmonary bands (too tight or too loose) and stenting of
the ductus arteriosus when aortic coarctation is present have been
addressed as a result of published expertise from leading centres.8 Although
long-term follow-up data are still not known, short- and medium-term
follow-up is impressive and comparable to surgical results.7,9–12
Avoiding cardiopulmonary bypass with hybrid therapy does not mean
that these patients are less prone to interstage problems and mortality.
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These infants remain high-risk patients. Strict ambulatory follow-up is
mandatory to anticipate potential complications. For example, insufficient
stenting of the ductus arteriosus, obstruction of one or even both
pulmonary arteries and dysfunction of the right ventricle in systemic
position are potential acute problems that can occur at any time between
the first and second intervention.11
Isolated Ventricular Septal Defect or in Association with
Other Congenital Malformations
VSD is one of the most frequent congenital heart diseases. It can be
isolate, multiple or associated with more complex congenital
malformation such as double outlet right ventricle or transposition of the
great arteries. Most of the VSDs are localised in the perimembranous area
of the interventricular septum, and only 20% are in the muscular part.
Specific devices have been developed for interventional closure of
perimembranous and muscular VSDs. Interventional closure of muscular
VSDs is one of the most challenging percutaneous interventions because
of high anatomical variability, different thickness of the muscular septum
and the presence of trabeculations on the right ventricular side. In
addition, infants with symptomatic VSD demonstrate signs of congestive
heart failure and failure to thrive and are potentially too unstable for a
long catheterisation procedure. Thus, most of them are not suitable for
percutaneous closure. On the other hand, surgical muscular VSD closure
could be difficult for the same anatomical reason (localisation of the VSD
in the muscular septum and visibility of this area in an arrested heart). 
To overcome these problems and find a better strategy, a hybrid therapy
has been developed. The procedure is performed under TEE guidance and
after median sternotomy or mini-sternotomy. A purse ring suture is placed
on the right ventricular free wall opposite to the VSD, allowing the VSD to
be crossed directly with a needle. An appropriately sized sheath is then
advanced through the VSD. Before the device is released the location of
the device is checked with TEE. The same procedure could be performed,
for example, in the case of repair of transposition of great arteries with
VSD or repair of a double outlet ventricle. The advantages are the
shortened time of cardiopulmonary bypass and simplification of an already
complex surgery. In cases of multiple muscular VSD (so-called Swiss cheese
presentation) the procedure can be repeated, allowing every significant
defect to be closed.12-16
Overall results are excellent and the avoidance of cardiopulmonary bypass
for these sick infants is a great advance. 
Intraoperative Stenting of Pulmonary Arteries
Congenital heart disease with right ventricular obstruction is frequently
associated with stenotic or hypoplastic peripheral pulmonary arterial
branches. Recurrent stenosis of the pulmonary arteries is usual and
impairs normalisation of right ventricular pressure. Redo surgery has the
disadvantage that dissection and recognition of structures are made
more difficult. On the other hand, percutaneous intervention is possible
with balloon angioplasty (standard balloon, high-pressure balloon or
cutting balloon) or with stent deployment. The main issues in these
cases are either vascular access or reaching the lesion in a satisfactory
fashion for the intervention. Tortuous pulmonary branches and cardiac
conduit between right ventricle and pulmonary artery are some of the
obstacles for cardiologists. 
Again, hybrid therapy offers possibilities to overcome these challenging
situations. Usually, the procedure is monitored by fluoroscopy and
performed at the time of another planned surgery, such as a conduit
change. According to the type of lesions, the surgeon either provides
access to the lesion (through the main artery purse ring suture, for
example) or the main pulmonary is opened and direct stenting of
pulmonary arteries achieved under direct visualisation.12,17-19
In these complex patients with different levels of right ventricular outflow
tract obstruction, any effort to reduce the number of interventions and
their associated morbidity is of great help. In addition, improving in fewer
stages the obstruction and so decreasing right ventricular pressure will
hopefully contribute to improved long-term outcome.
Occlusions of Vascular or Surgical Structures 
During Surgery
In some particular settings, pulmonary perfusion is dependent on
abnormal vascular structure or surgical shunts. Surgical ligation of these
alternative ways of pulmonary flow could be difficult and time
consuming for the surgeon. A stepped approach with closure of devices
of these structures followed by surgery is almost impossible without a
significant decrease of arterial saturation, leading to haemodynamic
instability of the patient.
With a hybrid procedure, occlusion of vascular or surgical structures is
feasible during surgery. Intervention is performed under fluoroscopy or
TEE guidance. According to anatomical location, size and length of the
shunt, the cardiologist will choose the most suitable type of device (coils
or vascular occluder) to be used for the intervention. Once obstruction of
the shunt is obtained, cardiopulmonary bypass is initiated and the
surgical procedure performed.
In these cases, collaborative planning between surgical and cardiological
teams is mandatory before surgery in order to obtain the best result for
the patient. Again, the main goal of this approach is to reduce duration
of surgery and cardiopulmonary bypass.
Issues, Debates and Conflicts in Hybrid Procedures
Increasing numbers of publications have addressed the problems raised by
hybrid procedures. The debate is particularly exacerbated when
considering HLHS or similar pathologies.20,21 Based on mortality, length of
stay in intensive care unit and hospital, and short- and medium-term
survival, many publications have focused on whether hybrid therapy offers
the same results as a standard surgical approach. In these articles, hybrid
therapy is offered, most of the time, to patients facing high-risk surgery,
and standard surgery is offered to those facing simpler surgeries.22,23 Most
of the published experience comes from leading centres where a high
amount of surgery is performed. Their experience, however, may not
reflect that of other centres worldwide. Indeed, depending on the surgical
team and intensive care unit experience, differences in mortality or other
short-term issue can vary dramatically. In our opinion the main issue is not
whether hybrid therapy is performed as well as a standard surgical
approach but whether changing our surgical strategy for a less aggressive
strategy will change long-term neuro-developmental outcomes. 
Conclusion
Congenital heart disease represents a large panel of different diseases,
with different problematic clinical and follow-up outcomes. In this
area, the development of hybrid procedures is a promising tool. 
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This new way of thinking allows new strategies of palliation or
correction to be offered for simple and complex congenital heart
diseases. For some rare cases it may be a unique way of allowing an
acceptable result for the patient. Although many of these types of
intervention are already standardised, many will never be. Some cases
are so unusual that the applied strategy would never be comparable
with any ‘gold standard’ surgery. The main issue of implementing a
hybrid therapy programme is a trend in avoiding surgical insults to infants
and children with congenital heart disease. This has been carried out by
creating or inventing new procedure strategies. This will be acceptable
only if these new strategies obtain results as good as the previous ones
and demonstrate a beneficial effect on the long-term follow-up of
patients. This question is still unanswered at this point.
Finally, in our opinion, hybrid therapy is an alternative approach for
dealing with congenital heart disease and a great opportunity for surgical
and medical teams to think and plan together to overcome the
limitations of the usual surgical or interventional procedures. ■
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New Developments in the Treatment of Hypoplastic 
Left Heart Syndrome
Alsoufi B, Bennetts J, Verma S and Caldarone CA
Pediatrics, 2007;119(1):109–17.
In the current decade, the prognosis of newborns with hypoplastic
left heart syndrome, previously considered a uniformly fatal
condition, has dramatically improved through refinement of rapidly
evolving treatment strategies. These strategies include various
modifications of staged surgical reconstruction, orthotopic heart
transplantation and hybrid palliation using ductal stenting and
bilateral pulmonary artery banding. The variety of treatment
approaches are based on different surgical philosophies, and each
approach has its unique advantages and disadvantages. Nonetheless,
multiple experienced centres have reported improved outcomes in
each one of those modalities. 
The purpose of this review is to outline recent developments in the
array of currently available management strategies for neonates with
hypoplastic left heart syndrome. Because the vast majority of deaths in
this patient population occur within the first months of life, the focus
of the review will be evaluation of the impact of these management
strategies on survival in the neonatal and infant periods. ■
Improving the Outcome of High-risk Neonates with
Hypoplastic Left Heart Syndrome: Hybrid Procedure or
Conventional Surgical Palliation?
Pizarro C, Derby CD, Baffa JM, Murdison KA and Radtke WA
Eur J Cardiothorac Surg, 2008;33(4):613–18.
Despite significant progress, surgical outcome for high-risk patients with
hypoplastic left heart syndrome (HLHS) remains suboptimal. The hybrid
palliation lessens the initial operative insult and is expected to improve
overall survival; however, the outcome of this management sequence is
unknown. In a retrospective review of all high-risk neonates undergoing
initial palliation for HLHS either by hybrid or stage I Norwood procedure
at a single institution between January 2001 and December 2006, 
the two strategies were compared using survival after stage II as the 
end-point for outcome. The cohort included 33 patients (14 hybrid and
19 Norwood). Patients undergoing hybrid palliation had a lower 
pre-operative pH, higher incidence of organ dysfunction and fewer
associated cardiac anomalies. Hospital mortality and interstage mortality
was 7/33 (21%) and 6/26 (23%) for the entire cohort, without significant
differences between the hybrid and the conventional Norwood
strategies. Although the hybrid approach reduces the initial surgical
insult, important interstage mortality and ongoing morbidity result in no
differences in survival compared with conventional surgical palliation. ■
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